Washington Trust Advisors, Inc. Charles River Laboratories International, Inc. Transaction History
Washington Trust Advisors, Inc.
- $1.13 Billion
- Q3 2024
A detailed history of Washington Trust Advisors, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 40 shares of CRL stock, worth $6,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 40
-0.0%
Holding current value
$6,590
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CRL
# of Institutions
691Shares Held
51.6MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$838 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$616 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$351 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$320 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.38B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...